| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43fe117d5e377852bbddf9b05a6702ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c500c6e58880b56b5cb1297f07876f25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0eb3e981dd7eddec8673b4e19b35708b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2009-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fa4944a52f5ad8685fc4ba14b9be9d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36b4d71e0feba730aff8cc9be565b361
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8560da444e58100693b376d4f646026b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a1f458522162598abfe31fa7d6eb2a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bbedf81591cd2ca6b352c3d5aa50736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45bd301c1ced31c97bf0ba83e8a7afde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_008064e2f3fbc559340ca7ef2ed7662a |
| publicationDate |
2011-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2340437-A1 |
| titleOfInvention |
Ykl-40 as a marker for gastrointestinal cancers |
| abstract |
The present invention relates to gastrointestinal cancers and methods for selecting a treatment for said gastrointestinal cancer in a subject. The present invention further relates to a methods of diagnosing the presence of and/or classifying the severity of a gastrointestinal cancer; together with methods for determining the effect of a therapy administered and/or the prognosis for a subject suffering from a gastrointestinal cancer, before, during or after administering the treatment. For all the methods applies that a determined level of YKL-40 above one or more reference levels indicates the treatment, the severity of the disease, the effect of the treatment and/or the prognosis of the subject. The reference level is typically a level obtained from healthy individuals or a level previously obtained from the same subject. The subject may suffer from any one or more gastrointestinal cancers, such as upper gastrointestinal cancers, and metastatic colorectal cancer. The present invention further relates to a kit and a device that may be used in the method of the present invention. |
| priorityDate |
2008-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |